Correlation Between Artec Consulting and Franklin Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artec Consulting and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artec Consulting and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artec Consulting Corp and Franklin Genomic Advancements, you can compare the effects of market volatilities on Artec Consulting and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artec Consulting with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artec Consulting and Franklin Genomic.

Diversification Opportunities for Artec Consulting and Franklin Genomic

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Artec and Franklin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Artec Consulting Corp and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Artec Consulting is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artec Consulting Corp are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Artec Consulting i.e., Artec Consulting and Franklin Genomic go up and down completely randomly.

Pair Corralation between Artec Consulting and Franklin Genomic

If you would invest  3,005  in Franklin Genomic Advancements on October 24, 2024 and sell it today you would earn a total of  2.52  from holding Franklin Genomic Advancements or generate 0.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.74%
ValuesDaily Returns

Artec Consulting Corp  vs.  Franklin Genomic Advancements

 Performance 
       Timeline  
Artec Consulting Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artec Consulting Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Artec Consulting is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Franklin Genomic Adv 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Genomic Advancements has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Franklin Genomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Artec Consulting and Franklin Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artec Consulting and Franklin Genomic

The main advantage of trading using opposite Artec Consulting and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artec Consulting position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.
The idea behind Artec Consulting Corp and Franklin Genomic Advancements pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges